Biomanufacturing Innovation

Langer, Eric
June 2012
Pharmaceutical Technology;Jun2012, Vol. 36 Issue 6, p64
Trade Publication
The article reports on the biopharmaceutical industry's view regarding technological innovations. According to BioPlan Associate's annual survey on bioprocessing trends and innovation, respondents reported high budget increases for new technologies and vendor respondents reported an average 1.9 increase in basic research and development (R&D) for product development. It also mentions major trends that contributed to improved bioprocessing which include legacy expression systems.


Related Articles

  • Impact of shareholding structure on Chinese bio-pharmaceutical listing companies' R & D investment. Liu Bin; Wei Changsheng // Journal of Chemical & Pharmaceutical Research;2014, Vol. 6 Issue 5, p858 

    R&D activities is an important way of knowledge accumulation and technological innovation, which promote the development of enterprises. R&D activities is becoming an important form of bio-pharmaceutical enterprise activity, which is typical of high-tech industries. This article studies the...

  • €2.3m research boost for biopharma industry.  // Engineers Journal;Jul/Aug2009, Vol. 63 Issue 6, p281 

    The article focuses on a 2.3 million euro-funded research network for the biopharmaceutical industry in Ireland as of 2009. The network is said to be aimed at delivering more efficient, reliable and less expensive processes for manufacturing biopharmaceutical medicines. Science, Technology,...

  • Embracing Innovation. Gottschalk, Uwe // BioPharm International;Oct2009 Downstream Processing 2010, p3 

    The article discusses innovative concepts in the U.S. biopharmaceutical industry. These concepts include the precipitation of host cell proteins, Protein A-free manufacturing, orthogonal virus clearance and the disposable chromatography. Such improvements in the sector indicate that...

  • BioPharma Industry Seeks Downstream Processing Advances. Langer, Eric S. // Pharmaceutical Processing;May2015, Vol. 30 Issue 4, p16 

    The article offers information on the intent of the biopharmaceutical industry to implement advances in downstream processing in the U.S. It mentions the benefits and implications of downstream processing in boosting the manufacturing capabilities of the industry. Moreover, it cites the...

  • Testing & Services Show Gains. Langer, Eric S. // Pharmaceutical Processing;Sep2012 Supplement, Vol. 27, p13 

    The article reports that according to the journal's 9th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, outsourcing budgets will rise by 9.3 percent over 2013, and much of this spending will go towards testing and related services. Analytical testing...

  • Mixed scores for European research. Chipman, Andrea // Nature;11/1/2007, Vol. 450 Issue 7166, p16 

    The article focuses on the issues concerning the 2007 European Union (EU) Industrial Research & Development (R&D) Investment Scoreboard, a report that surveyed the 1,000 biggest R&D spenders in the EU, which is released in October 2007. The study, which is conducted by the European Commission,...

  • Innovation vs. R&D Spending.  // Multichannel News;3/26/2012, Vol. 33 Issue 13, p8 

    The article reports on the survey conducted by Booz & Co. which compares the 10 rated most innovative companies against the 10 biggest research and development (R & D) spenders globally.

  • Troublesome Signs for Bio/Pharmaceutical R&D. Miller, Jim // BioPharm International;Dec2011, Vol. 24 Issue 12, p18 

    The author discusses the troublesome signs for biopharmaceutical and pharmaceutical research and development. The author says that the contract manufacturing organization (CMO) and contract development and manufacturing organization (CDMO) report the demand for the late-stage clinical trial. He...

  • PHARMA CAPSULES.  // Pharmaceutical Technology;Apr2011, Vol. 35 Issue 4, p87 

    The article presents questions and answers related to the pharmaceutical industry in the U.S. including the challenges in the industry and the emerging trends in pharmaceutical technology.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics